Chinese Neurosurgical Journal Report Identifies FAM111B as Key Molecular Driver of Glioma Progression
Study shows FAM111B overexpression enhances glioma malignancy via PI3K/AKT pathway, suggesting a novel treatment target
BEIJING, CHINA, May 29, 2025 / EINPresswire.com / -- Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China identified FAM111B, a DNA-repair-associated protein, as a key driver of glioma progression. The study shows that FAM111B overexpression enhances tumor growth and aggressiveness by activating the PI3K/AKT pathway. This is the first research to link FAM111B to gliomas, offering a promising new biomarker and therapeutic target for this intractable disease.
Gliomas are the most prevalent and aggressive form of primary brain tumors in adults, with dismal survival rates despite surgery, radiation, and chemotherapy. Scientists continue to search for molecular drivers that could serve as new therapeutic targets. Now, researchers led by Dr. Quan Du from Zhejiang Chinese Medical University and Westlake University in China have identified a promising candidate: a protein known as FAM111B.
'Our findings revealed that FAM111B affected glioma malignancy by modulating the PI3K/AKT pathway,' highlights lead researcher Dr. Du. 'This presents a new potential avenue for therapeutic intervention in the treatment of glioma.'
The study, published on May 19 2025, in the Chinese Neurosurgical Journal, is the first to examine the role of FAM111B in gliomas. Prior research had linked FAM111B to cell cycle regulation, DNA repair, and fibrosis-related diseases. However, its function in brain cancer was previously unknown.
Using genomic databases including The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), the research team found that FAM111B expression is significantly elevated in glioma tissues compared to healthy brain tissue. Moreover, higher expression levels correlated with older patient age, more advanced tumor grade, and poorer clinical outcomes—including reduced overall survival and disease-free survival. The authors confirmed these findings experimentally. Glioma cell lines and tumor samples showed significantly higher levels of FAM111B protein compared to normal tissues. When FAM111B was overexpressed in glioma cells, their proliferation, invasion, and migration dramatically increased. Conversely, knocking down FAM111B suppressed these malignant traits.
Further, in vivo experiments using mice confirmed FAM111B's role in promoting tumor growth. Mice injected with glioma cells overexpressing FAM111B developed significantly larger and heavier tumors than controls.
To uncover the molecular mechanism behind these effects, the team conducted pathway enrichment analysis. Results pointed strongly to the PI3K/AKT signaling cascade—a pathway long associated with tumor growth and resistance to therapy. Further tests showed that FAM111B overexpression increased phosphorylation of PI3K and AKT, while silencing the protein had the opposite effect.
'FAM111B regulates glioma cell malignant features via the PI3K/AKT pathway,' the Dr. Du wrote. 'These results support the hypothesis that FAM111B influences the malignant features of glioma cells primarily through the PI3K/AKT pathway.'Treatment with a PI3K inhibitor reversed the aggressive behavior caused by FAM111B overexpression, strongly suggesting a direct regulatory role. This not only strengthens the case for FAM111B as a key driver of glioma but also highlights it as a promising therapeutic target. The study's strength lies in its comprehensive approach, combining bioinformatics, cell culture, animal modeling, and molecular assays. However, the authors acknowledge the study's limitations, particularly the small patient sample size and the need for broader validation across multiple research centers.
Nonetheless, the implications are significant. Identifying FAM111B as an independent prognostic marker and a key modulator of a known cancer pathway adds a valuable tool to the glioma research arsenal.
While therapies targeting the PI3K/AKT pathway already exist, this research may pave the way for more precise, FAM111B-guided interventions. 'FAM111B has emerged not only as a critical biomarker for the development of glioma,' Dr Du concludes, 'but also as a promising novel target for therapeutic intervention.'
As researchers work to solve the complex puzzle of brain cancer, FAM111B may soon take center stage.
***
Reference
Title of original paper: The role of FAM111B in the malignant progression and molecular regulation of human glioma through the PI3K/Akt pathway
Journal: Chinese Neurosurgical Journal
DOI: https://doi.org/10.1186/s41016-025-00395-6
Yi Lu
Chinese Neurosurgical Journal
+86 10 5997 8478
[email protected]
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
12-06-2025
- Associated Press
WILDFIRES: 98% of People in Canada Living with Asthma Say Poor Air Quality Worsens Their Health
7 Practical Steps to Keep Your Asthma Managed This Wildfire Season TORONTO,, ONTARIO, CANADA, June 12, 2025 / / -- As wildfires once again rage across the country, Asthma Canada is urging people living with asthma to take serious precautions. Wildfire smoke contains harmful pollutants, including fine particulate matter that can settle deep in the lungs. For the more than 4.6 million Canadians living with asthma, exposure to smoke can trigger severe symptoms—and, in some cases, lead to fatal asthma attacks. In Asthma Canada's most recent national survey, A Snapshot of Asthma in Canada, over 1,400 respondents shared how poor air quality—especially from wildfires—has affected their daily lives: 🔹 98% of respondents said poor air quality worsens their asthma 🔹 73% said poor air quality has directly caused their asthma to flare up severely 'It's not just about breathing issues—it's about your whole quality of life,' said Grace Pyatt, a nurse and professional beach volleyball player from Niagara, Ontario. 'I trained outdoors during wildfire season, and the smoke made everything harder. I was exhausted, constantly needing my rescue inhaler, and couldn't function outside of training. It took a toll on my mental and physical health—and it made me realize how serious wildfire smoke is for people with asthma.' The survey also revealed the mental health toll wildfire smoke takes on people with asthma: 🔹 85% reported a decline in their mental health during times of poor air quality 🔹 71% experienced anxiety that wildfire smoke could cause their asthma to flare up 'During wildfire season, I'm constantly on edge—worried that my asthma will flare up or that I'll have a serious attack. It's a terrifying feeling knowing it can be life-threatening,' said Charly Jarrett, a digital consultant from the West Kootenays, British Columbia. 'There's also a real sense of isolation. While others are outside enjoying the summer, I often have to stay indoors just to stay safe. It can feel incredibly lonely.' To help individuals protect themselves this summer, Asthma Canada has developed these essential tips: 🔷 7 Practical Steps to Manage Your Asthma During Wildfire Season 1. Stay informed: Keep track of local air quality updates and wildfire information from reliable sources like Environment Canada, The Weather Network, and the Government of Canada. 2. Have an updated Asthma Action Plan: Your plan should outline steps to take in case of worsening asthma symptoms or emergencies. Download your plan now. 3. Limit outdoor activities: Stay indoors as much as possible. Avoid physical exertion and exercise outdoors during peak pollution periods. If going outside is necessary: 🔹Wear a well-fitted N95 respirator mask to help protect against smoke particles. These can be purchased at pharmacies and online. 🔹Keep your reliever (usually blue) inhaler with you at all times in case asthma symptoms arise. 🔹When driving, keep your windows and vents closed and use air conditioning only in the 'recirculate' setting. 4. Use air purifiers and filters in your home: Use high-efficiency particulate air (HEPA) purifiers and keep windows and doors closed to prevent smoke infiltration. If using an air conditioner, choose the recirculation setting so outside air is not transferred inside. Avoid activities that contribute to indoor air pollution, such as smoking or using strong chemicals. 5. Take your medications as prescribed: Make sure you have necessary medications and supplies readily available and follow your prescribed asthma medication regimen, including both preventive and rescue medications. Consult your healthcare provider if you need to adjust your medication plan during episodes of poor air quality. 6. Stay hydrated: Drink plenty of fluids to keep your airways hydrated. This can help reduce symptoms and keep mucus thin, making it easier to cough up if necessary. 7. Watch Asthma Canada's Webinar: How Air Quality and Wildfires Affect Your Health In this informative session, respiratory experts Dr. Emily Brigham (Associate Professor, UBC) and Dr. Chris Carlsten (Director, Centre for Lung Health) explain how wildfire smoke and poor air quality affect your lungs—and share practical tips to help you stay healthy during wildfire season. 'Wildfire smoke can make asthma symptoms much worse, and for some, it can be life-threatening,' said Jeffrey Beach, President & CEO of Asthma Canada. 'If you have questions or concerns about managing your asthma—especially during wildfire season—we encourage you to reach out to our Asthma & Allergy HelpLine at 1-866-787-4050 or [email protected]. Our Certified Respiratory Educators are here to help you breathe easier and stay safe.' About Asthma Canada: Asthma Canada is the only national healthcare charity solely dedicated to improving the quality of life for people living with asthma and respiratory allergies. For more than 50 years, Asthma Canada has proudly served as the national voice for people in Canada living with asthma. Our mission is to help people living with asthma lead healthy lives through education, advocacy, and research. Our vision is a future without asthma. For more information, please visit About Asthma in Canada: 🔹Over 4.6 million people are living with asthma in Canada 🔹Including over 900,000 children under 19 and over 800,000 adults over 65 🔹As many as 465,000 people living with asthma in Canada have severe asthma 🔹Including over 45,000 children under 19 🔹Asthma is Canada's third most chronic disease 🔹Over 300 families lose a loved one to asthma each year 🔹$4.2 billion is the expected cost of asthma to the Canadian economy by 2030 annually 🔹317 people are diagnosed with asthma every day in Canada 🔹80,000 visits are made to the emergency room each year because of asthma attacks 🔹Some people in Canada are hit harder by asthma; it is 40% more prevalent among First Nations, Inuit and Metis communities than the general population in Canada. Pauric Keegan Asthma Canada +1 866-787-4050 [email protected] Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
12-06-2025
- Associated Press
Summit Spine Continues Expansion into North Carolina, Partners with Dr. Louis Torres
'We are thrilled to welcome Dr. Louis Torres to our team as we continue to enhance access to advanced pain care for the Fayetteville community.'— Dr. Amit Patel, CEO and Founder of Summit Spine & Joint Centers FAYETTEVILLE, NC, UNITED STATES, June 12, 2025 / / -- Summit Spine & Joint Centers, a leading multi-location provider of minimally invasive spine care, proudly announces the appointment of Dr. Louis Torres as the newest physician leader. Dr. Torres will support Summit's growing North Carolina operations – which operate under the Integrated Pain Solutions brand. Dr. Torres' arrival represents a strategic milestone in the organization's continued commitment to delivering best-in-class musculoskeletal (MSK) solutions to the Fayetteville region. With an established presence spanning 30 locations in Georgia, 11 in North Carolina, one in Tennessee, and two in South Carolina, Summit Spine & Joint Centers has earned widespread recognition for its excellence in pain management and compassionate patient care. The addition of Dr. Torres strengthens the Company's dedication to expanding access to high-quality, patient-focused care for individuals suffering from chronic pain across the Southeast. Specializing in the diagnosis and treatment of complex conditions—including neck and back pain, sciatica, herniated discs, headaches, pelvic and musculoskeletal pain, and neuropathic disorders—Summit Spine leverages state-of-the-art technologies to deliver precision-based care tailored to each patient's needs. 'We are thrilled to welcome Dr. Louis Torres to our team as we continue to enhance access to advanced pain care for the Fayetteville community,' said Dr. Amit Patel, CEO and Founder of Summit Spine & Joint Centers. 'Our team of highly skilled physicians, nurses, and support staff are united by a shared mission: to improve lives by relieving pain and restoring function through innovative, minimally invasive treatments.' Dr. Torres, a Fayetteville-based physician with strong ties to the region, shared his enthusiasm for the partnership: 'I'm honored to expand access to advanced pain care in a community that means so much to me. Summit's focus on cutting-edge technology and its collaborative, patient-centered approach ensures that each patient receives the highest level of comprehensive and compassionate care.' Summit Spine & Joint Centers operates 17 ASCs and 44 clinics across four (4) states, with Georgia locations in Athens, Augusta, Braselton, Buford, Canton, Carrollton, Cartersville, Columbus, Commerce, Conyers, Covington, Cumming, Dalton, Decatur, East Cobb, Gainesville, Jasper, Johns Creek/Norcross, Lawrenceville, Lithia Springs, Newnan, Ringgold/Ft. Oglethorpe, Rome, Roswell, Savannah, Snellville, Stockbridge, Stonecrest/Lithonia, Winder, and Woodstock; North Carolina clinics in Asheboro, Beaufort, Fayetteville, Jacksonville, Laurinburg (2), Rockingham, Southern Pines, Wadesboro, Whiteville, and Wilmington; clinics South Carolina locations in Greenville and Spartanburg; and a clinic in Chattanooga, Tennessee. For more information call (864) 383-0669 or visit Samantha Montague Summit Spine & Joint Centers +1 404-784-5318 email us here Visit us on social media: LinkedIn Instagram Facebook Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
09-06-2025
- Yahoo
Elizabeth Loboa Named Provost at the University of Denver
DENVER, June 9, 2025 /PRNewswire/ -- Elizabeth Loboa is named the provost and executive vice chancellor at the University of Denver (DU). She comes to Denver to begin the next chapter in her impressive career as a leader in higher education. "Elizabeth boasts numerous successes in fostering an interdisciplinary education and research environment, and her guiding philosophy centers on student success, learning, and career outcomes," says DU Chancellor Jeremy Haefner. "Her background, values, expertise, and clear vision for the future of higher education make Elizabeth the perfect candidate for the role of DU's chief academic officer." Prior to DU, Loboa served for five years as the provost and senior vice president for academic affairs at Southern Methodist University (SMU). In addition to leading the university toward earning the R1 Carnegie Classification, she also worked alongside her colleagues to see a 56% increase in student applications. Under Loboa's leadership, SMU developed several programs aimed at providing faculty opportunities to develop skills and pursue leadership roles. Her efforts were guided by a commitment to the students, working closely with deans and others to seek opportunities to improve the student experience. "The work DU is engaged in now to provide an exceptional and holistic education to its students is deeply inspiring and shaping the future of higher education," Loboa says. "I look forward to joining the chancellor and deans to even further strengthen DU's academic experience, attract great students and educators, support faculty development, and produce research that improves the world." Loboa graduated from the University of California Davis with a degree in mechanical engineering. She earned her master's and doctorate from Stanford in biomechanical engineering and mechanical engineering, respectively. Prior to SMU, Loboa served as the dean and Ketcham Professor at the University of Missouri College of Engineering. She also held various professorship roles at the University of North Carolina Chapel Hill and North Carolina State University. Loboa will join DU in August. She replaces Mary Clark who is returning to full time teaching at DU. About the University of Denver:The University of Denver is a private university that empowers students who want to make a difference. Recognized as a top research university, DU students benefit from an experience that channels passion to serve the public good. Learn more at or visit the University's newsroom. View original content to download multimedia: SOURCE University of Denver Sign in to access your portfolio
